Market Overview

Global Systemic Psoriasis Therapeutics Market 2018-2022 - Rise in Cost of Systemic Psoriasis Therapy / Intro of Biologics / Gene Therapy for Psoriasis / Use of Combination Therapy - ResearchAndMarkets.com

Share:

The "Global
Systemic Psoriasis Therapeutics Market 2018-2022"
report has
been added to ResearchAndMarkets.com's offering.

The Global Systemic Psoriasis Therapeutics Market to grow at a CAGR of
10.07% during the period 2018-2022.

This report has been prepared based on an in-depth market analysis with
inputs from industry experts. The report covers the market landscape and
its growth prospects over the coming years. The report also includes a
discussion of the key vendors operating in this market. To calculate the
market size, the report considers the revenue generated from sale of
different systemic psoriasis therapeutics.

One trend affecting this market is the rise in cost of systemic
psoriasis therapy. The cost of the treatment depends on the severity of
the disease. The first line of treatment is usually a systemic agent,
and if ineffective a more potent systemic agent is used which increases
the cost of treatment.

According to the report, one driver influencing this market is the need
for affordable therapies. Topical treatments are most often purchased
medication. Biologics are the most expensive medication and treatment
failure can increase the medication cost.

Further, the report states that one challenge affecting this market is
the patent expiry of drugs. The patent for major biologics for systemic
psoriasis therapy have expired, which increases chances of adoption of
biosimilars.

Key vendors

  • AbbVie
  • Amgen
  • Celgene
  • Johnson & Johnson

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

PART 05: MARKET SIZING 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: PIPELINE ANALYSIS

  • Pipeline analysis
  • Discontinued psoriasis therapies

PART 08: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Small molecules
  • Biologics
  • Market opportunity by product

PART 09: MARKET SEGMENTATION BY ROA

  • Oral
  • Parenteral

PART 10: MARKET SEGMENTATION BY SEVERITY OF DISEASE

PART 11: MARKET SEGMENTATION BY END-USER

  • Segmentation by end-user
  • Hospitals
  • Retail pharmacies

PART 12: CUSTOMER LANDSCAPE

PART 13: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Market opportunity

PART 14: DECISION FRAMEWORK

PART 15: DRIVERS AND CHALLENGES

PART 16: MARKET TRENDS

  • Rise in cost of systemic psoriasis therapy
  • Introduction of biologics
  • Gene therapy for psoriasis
  • Use of combination therapy
  • Research in precision healthcare infrastructure

PART 17: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 18: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors

For more information about this report visit https://www.researchandmarkets.com/research/d66xbp/global_systemic?w=4

View Comments and Join the Discussion!